article thumbnail

UK regulator gives green light to combination for multiple myeloma

Drug Discovery World

Seven years of trial data DLd is licensed and has been available for use in Europe since 2019. The post UK regulator gives green light to combination for multiple myeloma appeared first on Drug Discovery World (DDW).

article thumbnail

How MMR-deficient colorectal cancers regulate their growth

Drug Target Review

For the first time, scientists at UCL and University Medical Center Utrecht have observed bowel cancer cells’ ability to regulate their growth using a genetic on-off switch to increase their likelihood of survival.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Article Periodic Thank You Commission proposes exemptions to UV-328 ban under POPs Regulation

Agency IQ

Commission proposes exemptions to UV-328 ban under POPs Regulation The European Commission plans to implement exemptions introduced under the Stockholm Convention’s 2023 ban of UV-328, an ultraviolet-light absorbing persistent organic pollutant (POP). This exemption is in accordance with Article 4(1)b of the POPs Regulation.

article thumbnail

Analysis Chemical Thank You The 103 regulations the EPA is currently working on

Agency IQ

The 103 regulations the EPA is currently working on On July 5, 2024, the EPA published its Spring 2024 Unified Agenda, which reveals what regulations the agency is planning on releasing by the end of the year and beyond.

article thumbnail

Medicare program spent $1.8 billion in 2019 on drugs without confirmed clinical benefits

The Pharma Data

billion in Medicare funds in 2019 on drugs whose clinical benefits have yet to be confirmed by the Food and Drug Administration, a new study led by researchers from the Johns Hopkins Bloomberg School of Public Health suggests. billion on 36 of these drugs across 55 indications in 2019. federal government spent an estimated $1.8

FDA 52
article thumbnail

Study shines a light on representation in clinical research

Drug Discovery World

GSK’s retrospective study looked at clinical trial demographic data from 495 GSK and ViiV clinical trials involving US-based participants from the period 2002 to 2019. The post Study shines a light on representation in clinical research appeared first on Drug Discovery World (DDW).

article thumbnail

Article EMA Thank You What you need to know about the status of the proposed EMA fees regulation

Agency IQ

The adoption of a “fees payable” regulation, Council Regulation (EC) No 297/95 , permitted (and continues to permit) the regulator to assess fees for many of the services it provides to medicines developers. There are other fee-related regulations as well. See AgencyIQ’s analysis of the fees explanatory note correction.]